Hannah Fraser

2.0k total citations
29 papers, 675 citations indexed

About

Hannah Fraser is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Hannah Fraser has authored 29 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 20 papers in Hepatology and 13 papers in Infectious Diseases. Recurrent topics in Hannah Fraser's work include HIV, Drug Use, Sexual Risk (21 papers), Hepatitis C virus research (20 papers) and HIV/AIDS Research and Interventions (13 papers). Hannah Fraser is often cited by papers focused on HIV, Drug Use, Sexual Risk (21 papers), Hepatitis C virus research (20 papers) and HIV/AIDS Research and Interventions (13 papers). Hannah Fraser collaborates with scholars based in United Kingdom, United States and France. Hannah Fraser's co-authors include Peter Vickerman, Matthew Hickman, Natasha K. Martin, I. McConnell, Michael N Dawson, G. Wells, Josephine G. Walker, Adam Trickey, Aaron G. Lim and Margaret May and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

Hannah Fraser

27 papers receiving 653 citations

Peers

Countries citing papers authored by Hannah Fraser

Since Specialization

Citations

This map shows the geographic impact of Hannah Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Fraser more than expected).

Fields of papers citing papers by Hannah Fraser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Fraser. The network helps show where Hannah Fraser may publish in the future.

Co-authorship network of co-authors of Hannah Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Fraser. A scholar is included among the top collaborators of Hannah Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Fraser. Hannah Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, Vietnam 2025 ·International Journal of Drug Policy ·Adam Trickey, Josephine G. Walker, Phạm Minh Khuê, Tran Thi Hong, Nguyễn Thanh Bình, Catherine Quillet, Roselyne Vallo, (unknown), Khuat Thi Hai Oanh, Hannah Fraser, (unknown), (unknown), (unknown), Don C. Des Jarlais, Vinh Vu Hai, Nicolas Nagot, Didier Laureillard, Jack Stone, Peter Vickerman	1
2	Trends and factors associated with illicit drug use in South Africa: Findings from multiple national population-based household surveys, 2002–2017 2024 ·International Journal of Drug Policy ·(unknown), Jack Stone, Andrew Scheibe, Hannah Fraser, Leigh F. Johnson, Peter Vickerman	0
3	Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community 2024 ·Journal of Viral Hepatitis ·Jennifer R. Havens, Michelle R. Lofwall, April M. Young, Michele Staton, (unknown), Hannah Fraser, Peter Vickerman, Sharon Walsh	0
4	Impact and cost‐effectiveness of the national scale‐up of HIV pre‐exposure prophylaxis among female sex workers in South Africa: a modelling analysis 2023 ·Journal of the International AIDS Society ·Jack Stone, (unknown), Gabriela B. Gomez, Robyn Eakle, Christinah Mukandavire, Hasina Subedar, Hannah Fraser, Marie‐Claude Boily, Sheree Schwartz, Jenny Coetzee, Kennedy Otwombe, Minja Milovanovic, Stefan Baral, Leigh F. Johnson, François Venter, Helen Rees, Peter Vickerman	10
5	Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study 2023 ·BMC Infectious Diseases ·Adam Trickey, (unknown), Erika Duffell, Anna McNaughton, Lina Nerlander, Josephine G. Walker, Hannah Fraser, Matthew Hickman, Peter Vickerman, Ellen Brooks‐Pollock, Hannah Christensen	10
6	Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya 2022 ·AIDS ·Jack Stone, Hannah Fraser, Josephine G. Walker, Nyashadzaishe Mafirakureva, (unknown), Charles M. Cleland, (unknown), Helgar Musyoki, Wanjiru Waruiru, (unknown), Parinita Bhattacharjee, Nok Chhun, (unknown), Matthew J. Akiyama, Peter Cherutich, (unknown), Ann Kurth, Niklas Luhmann, Peter Vickerman	6
7	The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study 2022 ·The Lancet Public Health ·Jack Stone, Andreea Adelina Artenie, Matthew Hickman, Natasha K. Martin, Louisa Degenhardt, Hannah Fraser, Peter Vickerman	22
8	Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020) 2022 ·International Journal of Drug Policy ·Norah Palmateer, (unknown), (unknown), (unknown), (unknown), Jack Stone, Hannah Fraser, Thomas Seyler, Yuejiao Duan, Richard Tran, Kirsten M. A. Trayner, (unknown), (unknown), Peter Vickerman, Matthew Hickman, Sharon Hutchinson	34
9	Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C 2021 ·BMJ Open ·Jennifer R. Havens, (unknown), Hannah Fraser, Michelle R. Lofwall, Michele Staton, April M. Young, (unknown), Sharon Walsh, Peter Vickerman	2
10	Overlapping Key Populations and HIV Transmission in Tijuana, Mexico: A Modelling Analysis of Epidemic Drivers 2021 ·AIDS and Behavior ·Hannah Fraser, Annick Bórquez, Jack Stone, Daniela Abramovitz, Kimberly C. Brouwer, David Goodman‐Meza, Matthew Hickman, Thomas L. Patterson, Jay G. Silverman, Laramie R. Smith, Steffanie A. Strathdee, Natasha K. Martin, Peter Vickerman	7
11	Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania 2021 ·Journal of the International AIDS Society ·Hannah Fraser, Jack Stone, (unknown), (unknown), (unknown), (unknown), (unknown), Josephine G. Walker, (unknown), Niklas Luhmann, (unknown), (unknown), (unknown), (unknown), Peter Vickerman	5
12	Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam–hepatitis C) 2020 ·BMJ Open ·Delphine Rapoud, Catherine Quillet, Phạm Minh Khuê, Vinh Vu Hai, Thị Thanh Bình Nguyễn, (unknown), (unknown), Jean‐Pierre Molès, Roselyne Vallo, Laurent Michel, Jonathan Feelemyer, Laurence Weiss, Maud Lemoine, Peter Vickerman, Hannah Fraser, (unknown), (unknown), Don C. Des Jarlais, Nicolas Nagot, Didier Laureillard	8
13	Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky 2020 ·International Journal of Drug Policy ·Jack Stone, Hannah Fraser, April M. Young, Jennifer R. Havens, Peter Vickerman	16
14	Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs 2019 ·Addiction ·Carolina Barbosa, Hannah Fraser, Thomas J. Hoerger, Alyssa Leib, Jennifer R. Havens, April M. Young, Alex H. Kral, Kimberly Page, Jennifer L. Evans, Jon E. Zibbell, Susan Hariri, Claudia Vellozzi, Lina Nerlander, John W. Ward, Peter Vickerman	29
15	The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study 2019 ·The Lancet. Gastroenterology & hepatology ·Adam Trickey, Hannah Fraser, Aaron G. Lim, Amy Peacock, Samantha Colledge‐Frisby, Josephine G. Walker, Janni Leung, Jason Grebely, Sarah Larney, Natasha K. Martin, Matthew Hickman, Louisa Degenhardt, Margaret May, Peter Vickerman	154
16	Modelling the impact of a national scale‐up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland 2018 ·Addiction ·Hannah Fraser, Christinah Mukandavire, Natasha K. Martin, David Goldberg, Norah Palmateer, Alison Munro, Avril Taylor, Matthew Hickman, Sharon Hutchinson, Peter Vickerman	14
17	Scaling‐up HCV prevention and treatment interventions in rural United States—model projections for tackling an increasing epidemic 2017 ·Addiction ·Hannah Fraser, Jon E. Zibbell, Thomas J. Hoerger, Susan Hariri, Claudia Vellozzi, Natasha K. Martin, Alex H. Kral, Matthew Hickman, John W. Ward, Peter Vickerman	66
18	Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination 2017 ·International Journal of Epidemiology ·Aaron G. Lim, Huma Qureshi, (unknown), Saeed Hamid, Charlotte Davies, Adam Trickey, Nancy Glass, (unknown), Hannah Fraser, Josephine G. Walker, Christinah Mukandavire, Matthew Hickman, Natasha K. Martin, Margaret May, Francisco Averhoff, Peter Vickerman	52
19	HIV treatment as prevention among people who inject drugs – a re-evaluation of the evidence 2016 ·International Journal of Epidemiology ·Hannah Fraser, Christinah Mukandavire, Natasha K. Martin, Matthew Hickman, Myron S. Cohen, William C. Miller, Peter Vickerman	20
20	Transmission of bovine spongiform encephalopathy to mice 1988 ·Veterinary Record ·Hannah Fraser, I. McConnell, G. Wells, Michael N Dawson	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact